Conclusion: The study asserted that H-FABP is a superior biomarker in terms of sensitivity, more superior to hs troponin T in diagnosing myocardial necrosis in the early phase of 0 - 6 hours, the golden hours of acute MI; which helps make important decisions on treatment methods, risk stratification and prognosis.